Answers are grounded in this paper and cite their sources.
Promising promiscuity: Guest editors Maria Laura Bolognesi and Andrea Cavalli set the stage for this ChemMedChem Special Issue on Polypharmacology and Multitarget Drugs. They highlight cases in which a departure from the "one target, one drug" paradigm has proven advantageous, with single molecules that can engage two or more targets to address a given pathology. Articles in this issue underscore the importance of focusing ever more attention to polypharmacology in drug discovery efforts.
No takes yet. Share an insight, caveat, or question.
Bolognesi et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: